149 related articles for article (PubMed ID: 17973593)
1. [Severe ulcerative colitis, with toxic megacolon, resolved with infliximab therapy].
Castro Fernández M; García Romero D; Sánchez Muñoz D; Grande L; Larraona JL
Rev Esp Enferm Dig; 2007 Jul; 99(7):426-7. PubMed ID: 17973593
[No Abstract] [Full Text] [Related]
2. Infliximab in the treatment of ulcerative colitis with toxic megacolon.
Sriram PV; Reddy KS; Rao GV; Santosh D; Reddy DN
Indian J Gastroenterol; 2004; 23(1):22-3. PubMed ID: 15106711
[TBL] [Abstract][Full Text] [Related]
3. Acute fulminant ulcerative colitis with toxic megacolon.
Igarashi C; Hori T; Yoshida M; Yokozawa M; Fujita S; Yonezawa K; Tosaka M; Yoshida Y
Acta Paediatr Jpn; 1997 Apr; 39(2):237-40. PubMed ID: 9141263
[TBL] [Abstract][Full Text] [Related]
4. Infliximab for ulcerative colitis.
Shields CJ; Winter DC
N Engl J Med; 2006 Mar; 354(13):1424-6; author reply 1424-6. PubMed ID: 16571891
[No Abstract] [Full Text] [Related]
5. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis.
Lawson MM; Thomas AG; Akobeng AK
Cochrane Database Syst Rev; 2006 Jul; (3):CD005112. PubMed ID: 16856078
[TBL] [Abstract][Full Text] [Related]
6. Infliximab for ulcerative colitis.
Reinshagen M
N Engl J Med; 2006 Mar; 354(13):1424-6; author reply 1424-6. PubMed ID: 16575949
[No Abstract] [Full Text] [Related]
7. [Effect of infliximab in the treatment of refractory inflammatory bowel disease with complication].
Lee KM; Kim JS; Shin DH; Cheong JY; Yoo BM; Kim JK; Lee KJ; Hahm KB; Kim JH; Cho SW
Korean J Gastroenterol; 2004 Nov; 44(5):259-66. PubMed ID: 15564805
[TBL] [Abstract][Full Text] [Related]
8. [Treatment of steroid-refractory ulcerative colitis with infliximab].
Castro Fernández M; García Díaz E; Romero M; Galán Jurado V; Rodríguez Alonso C
Gastroenterol Hepatol; 2003 Jan; 26(1):54-5. PubMed ID: 12525332
[No Abstract] [Full Text] [Related]
9. Oral tacrolimus for megacolon in patients with severe ulcerative colitis.
Narabayashi K; Inoue T; Sakanaka T; Iguchi M; Fujiwara K; Yorifuji N; Kakimoto K; Nouda S; Okada T; Ishida K; Abe Y; Masuda D; Takeuchi T; Fukunishi S; Umegaki E; Higuchi K
Intern Med; 2014; 53(16):1755-8. PubMed ID: 25130105
[TBL] [Abstract][Full Text] [Related]
10. Infliximab in Crohn's disease-associated toxic megacolon.
van Geenen EJ; Sachar DB
J Clin Gastroenterol; 2012 Apr; 46(4):321-3. PubMed ID: 21857531
[TBL] [Abstract][Full Text] [Related]
11. Is there a role for infliximab in severe ulcerative colitis?: the European experience.
Kohn A
Inflamm Bowel Dis; 2008 Oct; 14 Suppl 2():S234-5. PubMed ID: 18816780
[No Abstract] [Full Text] [Related]
12. [Three cases of severe and fulminating ulcerative colitis with megacolon treated with continuous intravenous infusion of cyclosporine].
Okano S; Sako M; Yoshimura N; Takazoe M
Nihon Shokakibyo Gakkai Zasshi; 2020; 117(2):157-164. PubMed ID: 32037361
[TBL] [Abstract][Full Text] [Related]
13. Acute abdominal pain in a child with inflammatory bowel disease.
Cameron FL; Armstrong L; Stenhouse E; Davis C; Russell RK
BMJ; 2013 Feb; 346():f563. PubMed ID: 23412439
[No Abstract] [Full Text] [Related]
14. Is infliximab effective for induction of remission in patients with ulcerative colitis?
Lichtenstein GR
Inflamm Bowel Dis; 2001 May; 7(2):89-93. PubMed ID: 11383596
[No Abstract] [Full Text] [Related]
15. Golimumab for moderately to severely active ulcerative colitis.
Kedia S; Ahuja V; Makharia GK
Expert Rev Clin Pharmacol; 2016 Oct; 9(10):1273-82. PubMed ID: 27498886
[TBL] [Abstract][Full Text] [Related]
16. [Toxic megacolon in the course of ulcerative colitis].
Dabrowska M
Pol Przegl Radiol Med Nukl; 1975; 39(4):483-8. PubMed ID: 1187415
[No Abstract] [Full Text] [Related]
17. Toxic megacolon associated with cytomegalovirus infection in a patient with steroid-naïve ulcerative colitis.
Inoue K; Wakabayashi N; Fukumoto K; Yamada S; Bito N; Yoshida N; Katada K; Uchiyama K; Ishikawa T; Handa O; Takagi T; Konishi H; Yagi N; Kokura S; Kishimoto M; Yanagisawa A; Naito Y
Intern Med; 2012; 51(19):2739-43. PubMed ID: 23037465
[TBL] [Abstract][Full Text] [Related]
18. Cost per remission and cost per response with infliximab, adalimumab, and golimumab for the treatment of moderately-to-severely active ulcerative colitis.
Toor K; Druyts E; Jansen JP; Thorlund K
J Med Econ; 2015 Jun; 18(6):437-46. PubMed ID: 25629655
[TBL] [Abstract][Full Text] [Related]
19. Current therapeutic recommendations: infliximab for ulcerative colitis.
Shen EH; Das KM
J Clin Gastroenterol; 2004 Oct; 38(9):741-5. PubMed ID: 15365397
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.
Su C; Salzberg BA; Lewis JD; Deren JJ; Kornbluth A; Katzka DA; Stein RB; Adler DR; Lichtenstein GR
Am J Gastroenterol; 2002 Oct; 97(10):2577-84. PubMed ID: 12385442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
